Articles
Healthcare payers are operating under sustained margin pressure. Rising specialty drug costs, post-COVID utilization shifts, Medicaid and Medicare Advantage margin compression, and increasing quality expectations are all converging at once. At the same time, organizations have more data…
Read MoreHealth plans don’t have a data problem. They have an action problem. Information from multiple domains, including claims, medical management, finance, network operations, quality, social risk, and customer experience, is spread across dozens of systems and vendors. …
Read MoreThe growing pressure on payer performance Healthcare organizations have more data than ever before yet achieving meaningful performance improvement has never been more difficult. Rising costs, specialty drug spend, and Medicare Advantage challenges…
Read MoreThe healthcare industry has reached a pivotal moment. Rising medical costs, tightening margins, increasing regulatory pressure, and the continued shift toward value-based care are forcing payers to rethink how they manage performance across…
Read MoreThe HIMSS Global Health Conference & Exhibition returned to Las Vegas in March 2026, bringing together thousands of healthcare leaders, clinicians, and innovators to explore the technologies and strategies shaping the future of…
Read MoreMarch 9-12, 2026 | Venetian Convention & Expo Center | Las Vegas As margin pressure intensifies and value-based care models mature, healthcare organizations are under more strain than ever. Payers and providers…
Read MorePayers increasingly recognize that social risk factors materially influence total cost of care, utilization, and quality performance. Yet for many organizations, social risk data remains siloed, underoperationalized, and inactionable. On a recent webinar,…
Read MoreGLP-1s present a major opportunity for organizations to improve clinical outcomes and reduce long-term healthcare costs. However, payers and providers must balance this potential with challenges such as high upfront spend, adherence issues,…
Read MoreFew pharmaceuticals have surged in popularity as fast as GLP-1s. This growth is well-justified. GLP-1s, a class of medications originally developed for diabetes and now widely used for weight management, are rapidly reshaping…
Read MoreKey takeaways from The Sequoia Project’s 2025 Annual Meeting to speed up healthcare data interoperability I recently attended The Sequoia Project’s 2025 Annual Meeting in Nashville. The Sequoia Project was formed in…
Read More